Are Jupiter Life Lin latest results good or bad?
Jupiter Life Line Hospitals' latest results show strong operational performance with record operating profit and net sales, but a 6.5% decline in profit after tax indicates some profitability challenges. Overall, the results are mixed, highlighting both growth and areas needing attention.
Jupiter Life Line Hospitals has reported its financial results for the quarter ending March 2025, showcasing a mixed performance. The company achieved an operating profit (PBDIT) of Rs 78.26 crore, which is the highest recorded in the last five quarters, indicating a consistent growth trend in operational profitability. The operating profit margin reached 23.95%, reflecting enhanced efficiency in its operations.Net sales also demonstrated positive momentum, amounting to Rs 326.74 crore, marking the highest level in the same five-quarter period. However, the profit after tax (PAT) was Rs 44.86 crore, which represents a decline of 6.5% compared to the average PAT from the previous four quarters. This decline points to challenges in profitability metrics that the company may face in the near term.
Overall, while Jupiter Life Line Hospitals exhibited strong operational performance with growth in both operating profit and net sales, the decline in PAT suggests areas that require attention. Additionally, the company saw an adjustment in its evaluation, reflecting the mixed nature of its financial results.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
